DonnaESalzmanMD
Oncology • Birmingham, ALHematologic Oncology
Associate Professor, Medicine, University of Alabama School of Medicine
Dr. Salzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NP2570
1720 2nd Ave S
Birmingham, AL 35294Phone+1 205-934-1908Fax+1 205-975-8394
Summary
- Associate Chief of Staff
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1990 - 1993
Louisiana State University School of MedicineResidency, Internal Medicine, 1986 - 1989- Louisiana State University School of Medicine in New OrleansClass of 1986
Certifications & Licensure
AL State Medical License 1995 - 2024
LA State Medical License 1986 - 2005
TX State Medical License 1991 - 1997- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia Start of enrollment: 2013 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant.Kyle Kidwell, Susan Bal, Kelly Godby, Gayathri Ravi, Luciano J Costa
Transplantation and Cellular Therapy. 2024-11-01 - 1 citationsLow-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignancies.Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Zaid Al-Kadhimi
Ejhaem. 2024-06-01 - 1 citationsImpact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia.Omer Jamy, Kendall Diebold, Kenneth Davis, Kimo Bachiashvili, Sravanti Rangaraju
Bone Marrow Transplantation. 2023-07-01
Journal Articles
- Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature
- Safety of Repeated Un-Manipulated Peripheral Blood Stem Cell Haploidentical Transplant for Graft FailureN Patil, D Salzman, J H Chewning, L Lamb, S Mineishi, Nature
Press Mentions
UAB’s Blood and Marrow Transplantation and Cell Therapy Program Celebrates 30 Years of Patient CareOctober 29th, 2021- BMT Survivor Study Finds Significant Breast Cancer Risk in Young Women Who Received Total Body IrradiationJuly 31st, 2020
NASA Light Technology Successfully Reduces Cancer Patients Painful Side Effects from Radiation and ChemotherapyMarch 7th, 2011
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
